Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
AssigneeBausch & Lomb Incorporated
InventorsErning Xia, Zhenze Hu, Praveen Tyle, Stephen Bartels
Life of this patent
Estimating the term…
Abstract
The invention comprises a method of treating dry eye in a patient in need of such treatment. The treatment comprises administering to a patient in need thereof an ophthalmic pharmaceutical composition comprising a corticosteroid and cyclosporine. In a further embodiment of the invention the corticosteroid is loteprednol etabonate. In yet a further embodiment of the invention the cyclosporine is present in the ophthalmic composition as either a natural or synthetic cyclosporine.
Claims27
Ophthalmic pharmaceutical compositions comprising a corticosteroid and a cyclosporin.
A method for the treatment of dry eye in a patient in need of such treatment, the treatment comprising administering to a patient in need thereof an effective amount of an ophthalmic pharmaceutical composition comprising a corticosteroid and cyclosporin.
A method for the treatment of diseases and disorders involving the anterior segment of the eye in a patient in need of such treatment, the treatment comprising administering to a patient in need thereof an effective amount of an ophthalmic pharmaceutical composition comprising a corticosteroid and cyclosporin to treat diseases and disorders involving the anterior segment of the eye.
Dependencies are inferred from the claim text.